Unknown

Dataset Information

0

Cutaneous Melanoma: An Overview of Physiological and Therapeutic Aspects and Biotechnological Use of Serine Protease Inhibitors.


ABSTRACT:

Background

Metastatic melanoma stands out as the most lethal form of skin cancer because of its high propensity to spread and its remarkable resistance to treatment methods.

Methods

In this review article, we address the incidence of melanoma worldwide and its staging phases. We thoroughly investigate the different melanomas and their associated risk factors. In addition, we underscore the principal therapeutic goals and pharmacological methods that are currently used in the treatment of melanoma.

Results

The implementation of targeted therapies has contributed to improving the approach to patients. However, because of the emergence of resistance early in treatment, overall survival and progression-free periods continue to be limited.

Conclusions

We provide new insights into plant serine protease inhibitor therapeutics, supporting high-throughput drug screening soon, and seeking a complementary approach to explain crucial mechanisms associated with melanoma.

SUBMITTER: Boleti APA 

PROVIDER: S-EPMC11357276 | biostudies-literature | 2024 Aug

REPOSITORIES: biostudies-literature

altmetric image

Publications

Cutaneous Melanoma: An Overview of Physiological and Therapeutic Aspects and Biotechnological Use of Serine Protease Inhibitors.

Boleti Ana Paula De Araújo APA   Jacobowski Ana Cristina AC   Monteiro-Alfredo Tamaeh T   Pereira Ana Paula Ramos APR   Oliva Maria Luiza Vilela MLV   Maria Durvanei Augusto DA   Macedo Maria Lígia Rodrigues MLR  

Molecules (Basel, Switzerland) 20240816 16


<h4>Background</h4>Metastatic melanoma stands out as the most lethal form of skin cancer because of its high propensity to spread and its remarkable resistance to treatment methods.<h4>Methods</h4>In this review article, we address the incidence of melanoma worldwide and its staging phases. We thoroughly investigate the different melanomas and their associated risk factors. In addition, we underscore the principal therapeutic goals and pharmacological methods that are currently used in the treat  ...[more]

Similar Datasets

| S-EPMC5438962 | biostudies-literature
| S-EPMC8410343 | biostudies-literature
| S-EPMC4934610 | biostudies-literature
| S-EPMC10829762 | biostudies-literature
| S-EPMC5812342 | biostudies-literature
| S-EPMC10512929 | biostudies-literature
| S-EPMC7178114 | biostudies-literature
| S-EPMC3744207 | biostudies-literature
| S-EPMC10169659 | biostudies-literature
| S-EPMC1855373 | biostudies-literature